Evidence map›Paper›PMID 25066276›Full record

ArticleJournal of virological methods2014

Development and clinical testing of a simple, low-density gel element array for influenza identification, subtyping, and H275Y detection.

Darrell P Chandler, Sara B Griesemer, Christopher Knickerbocker, Julia B Golova, Amine Lambarqui, Alexander N Perov, Cynthia Zimmerman, Cory Wiles, George B Rudy, Kirsten St George

Abstract readEvaluation Study
In one paragraph

Article in Journal of virological methods, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Darrell P ChandlerAkonni Biosystems, Inc., 400 Sagner Avenue, Suite 300, Frederick, MD 21701, United States. Electronic address: dchandler@akonni.com.
Sara B GriesemerLaboratory of Viral Diseases, Wadsworth Center, New York State Department of Health, 120 New Scotland Avenue, Albany, NY 12208, United States.
Christopher KnickerbockerAkonni Biosystems, Inc., 400 Sagner Avenue, Suite 300, Frederick, MD 21701, United States.
Julia B GolovaAkonni Biosystems, Inc., 400 Sagner Avenue, Suite 300, Frederick, MD 21701, United States.
Amine LambarquiAkonni Biosystems, Inc., 400 Sagner Avenue, Suite 300, Frederick, MD 21701, United States.
Alexander N PerovAkonni Biosystems, Inc., 400 Sagner Avenue, Suite 300, Frederick, MD 21701, United States.
Cynthia ZimmermanAkonni Biosystems, Inc., 400 Sagner Avenue, Suite 300, Frederick, MD 21701, United States.
Cory WilesAkonni Biosystems, Inc., 400 Sagner Avenue, Suite 300, Frederick, MD 21701, United States.
George B RudyAkonni Biosystems, Inc., 400 Sagner Avenue, Suite 300, Frederick, MD 21701, United States.
Kirsten St GeorgeLaboratory of Viral Diseases, Wadsworth Center, New York State Department of Health, 120 New Scotland Avenue, Albany, NY 12208, United States.

Funding

Diagnostic Influenza RT-PCR ArrayR44AI072784 · NIAID · AKONNI BIOSYSTEMS, INC. · PI CHANDLER, DARRELL P · 2009 to 2011
$3.0M
NIAID NIH HHS R 44 AI072784NIAID NIH HHS R44 AI072784PHS HHS U50/CCU223671
6 · The paper itself

Abstract

The objectives of this study were to develop a user-friendly, gel element microarray test for influenza virus detection, subtyping, and neuraminidase inhibitor resistance detection, assess the performance characteristics of the assay, and perform a clinical evaluation on retrospective nasopharyngeal swab specimens. A streamlined microarray workflow enabled a single user to run up to 24 tests in an 8h shift. The most sensitive components of the test were the primers and probes targeting the A/H1 pdm09 HA gene with an analytical limit of detection (LoD) <100 gene copies (gc) per reaction. LoDs for all targets in nasopharyngeal swab samples were ≤1000 gc, with the exception of one target in the seasonal A/H1N1 subtype. Seasonal H275Y variants were detectable in a mixed population when present at >5% with wild type virus, while the 2009 pandemic H1N1 H275Y variant was detectable at ≤1% in a mixture with pandemic wild type virus. Influenza typing and subtyping results concurred with those obtained with real-time RT-PCR assays on more than 97% of the samples tested. The results demonstrate that a large panel of single-plex, real-time RT-PCR tests can be translated to an easy-to-use, sensitive, and specific microarray test for potential diagnostic use.

Indexed as

Drug Resistance, ViralAntiviral AgentsHumansInfluenza A Virus, H1N1 SubtypeLaboratoriesMicroarray AnalysisMolecular Diagnostic TechniquesMolecular TypingMutant ProteinsNasopharynxNeuraminidaseOseltamivirRetrospective StudiesSensitivity and SpecificityTime FactorsViral ProteinsAntiviral AgentsMutant ProteinsNA protein, influenza A virusNeuraminidaseOseltamivirViral ProteinsEpidemiologyMicroarrayMolecular diagnosticOseltamivir resistanceSurveillance

Identifiers

PMID25066276
PMCPMC4175443

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.